Search by Drug Name or NDC

    NDC 63323-0315-94 Ganciclovir 500 mg/10mL Details

    Ganciclovir 500 mg/10mL

    Ganciclovir is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is GANCICLOVIR SODIUM.

    Product Information

    NDC 63323-0315
    Product ID 63323-315_6a576726-9413-47b3-aa25-145102205642
    Associated GPIs 12200030102110
    GCN Sequence Number 011753
    GCN Sequence Number Description ganciclovir sodium VIAL 500 MG INTRAVEN
    HIC3 W5A
    HIC3 Description ANTIVIRALS, GENERAL
    GCN 44620
    HICL Sequence Number 004558
    HICL Sequence Number Description GANCICLOVIR SODIUM
    Brand/Generic Generic
    Proprietary Name Ganciclovir
    Proprietary Name Suffix n/a
    Non-Proprietary Name GANCICLOVIR SODIUM
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 500
    Active Ingredient Units mg/10mL
    Substance Name GANCICLOVIR SODIUM
    Labeler Name Fresenius Kabi USA, LLC
    Pharmaceutical Class Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090658
    Listing Certified Through 2024-12-31

    Package

    NDC 63323-0315-94 (63323031594)

    NDC Package Code 63323-315-94
    Billing NDC 63323031594
    Package 25 VIAL in 1 TRAY (63323-315-94) / 10 mL in 1 VIAL (63323-315-41)
    Marketing Start Date 2010-06-28
    NDC Exclude Flag N
    Pricing Information N/A